Jul 16, 2021
COVID-19, Ivermectin, a dissolving pacer, clinician well-being, and finerenone are discussed this week.
1 COVID-19
US 'Losing Time' Against Delta Variant, NIH Chief Says https://www.medscape.com/viewarticle/954882
Ivermectin for COVID: How Do We Know What to Believe? https://www.medscape.com/viewarticle/954681
2 Dissolving Pacemaker
Dissolving Pacemaker Impressive in Early Research https://www.medscape.com/viewarticle/954774
3 Clinician Well-being
Global Heart Organizations Unite to Promote Clinician Well-Being https://www.medscape.com/viewarticle/954803
Clinician Well-Being: Addressing Global Needs for Improvements in the Health Care Field A Joint Opinion From the American College of Cardiology, American Heart Association, European Society of Cardiology, and the World Heart Federation https://www.jacc.org/toc/jacc/0/0
From Triple to Quadruple Aim: Care of the Patient Requires Care of the Provider https://www.annfammed.org/content/12/6/573.full
Bullying in Academic Medicine Rife, Underreported https://www.medscape.com/viewarticle/954709
4 Finerenone
FDA Approves Finerenone (Kerendia) for Slowing CKD in Type 2 Diabetes https://www.medscape.com/viewarticle/954606
You may also like:
Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine https://www.medscape.com/features/public/machine
The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact news@medscape.net